Fig. 2From: The vascular function effects of adding exenatide or meal insulin to basal insulin therapy in early type 2 diabetesVascular measures in each of the treatment arms during the trial: (Panel A) systolic blood pressure; (Panel B) diastolic blood pressure; (Panel C) heart rate; and (Panel D) reactive hyperemia index (RHI)Back to article page